Q3 2023 Holdings
Filed 2023-11-14 | 65 holdings | $296.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals in(VRTX) | COM | 92532F100 | $7.3M | 21,000 | 2.5% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $7.7M | 33,959 | 2.6% |
| Aurinia Pharmaceuticals I(AUPH) | COM | 05156V102 | $8.1M | 1,040,530 | 2.7% |
| Uniqure N.V. COM Eur0.05(QURE) | SHS | N90064101 | $8.3M | 1,241,500 | 2.8% |
| Ultragenyx Pharmaceutical(RARE) | COM | 90400D108 | $8.9M | 250,052 | 3.0% |
| Mirati Therapeutics Inc C(MRTXEUR) | COM | 60468T105 | $9.4M | 216,000 | 3.2% |
| Harmony Biosciences Holdi(HRMY) | COM | 413197104 | $10.3M | 314,500 | 3.5% |
| Biogen Inc Common Stock(BIIB) | COM | 09062X103 | $10.3M | 40,200 | 3.5% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $10.4M | 758,355 | 3.5% |
| Supernus Pharmaceuticals(SUPN) | COM | 868459108 | $11.8M | 426,500 | 4.0% |
| Biomarin Pharmaceutical I(BMRN) | COM | 09061G101 | $13.6M | 153,656 | 4.6% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $16.5M | 317,856 | 5.6% |
| Gilead Sciences Inc Commo(GILD) | COM | 375558103 | $17.5M | 233,584 | 5.9% |
| Incyte Corp Inc COM(INCY) | COM | 45337C102 | $20.7M | 358,454 | 7.0% |
| Amgen Inc COM(AMGN) | COM | 031162100 | $21.3M | 79,246 | 7.2% |